Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
34,309,263
-
Total 13F shares
-
7,623,491
-
Share change
-
+401,692
-
Total reported value
-
$92,186,011
-
Price per share
-
$12.09
-
Number of holders
-
21
-
Value change
-
+$4,858,661
-
Number of buys
-
11
-
Number of sells
-
6
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q1 2018
As of 31 Mar 2018,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,623,491 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Opaleye Management Inc., 683 Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, venBio Select Advisor LLC, PUTNAM INVESTMENTS LLC, ACUTA CAPITAL PARTNERS, LLC, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and GRANAHAN INVESTMENT MANAGEMENT INC/MA.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.